Many patients experience markedly fewer and less severe gastrointestinal side effects, such as nausea and vomiting, compared to Wegovy
Plaintiffs in the litigation report experiencing these specific digestive system complications: Gastroparesis (stomach paralysis): The most common injury alleged in lawsuits, this condition involves partial or complete paralysis of stomach muscles that prevents proper digestion and can persist even after discontinuing medication Ileus (intestinal blockage): Added to FDA warning labels in September 2023 after post-marketing reports, this condition stops intestinal movement and can lead to life-threatening complications including infection and tissue death Intestinal obstruction and pseudo-obstruction: Physical or functional blockages requiring emergency hospitalization and often surgical intervention to prevent bowel perforation Chronic severe symptoms: Persistent vomiting, uncontrollable nausea, dangerous dehydration requiring IV fluids, and electrolyte imbalances necessitating repeated emergency department visits The FDAs decision to update warning labels demonstrates growing concern about these complications
When you work closely with a healthcare professional, you can receive personalized guidance on how to use semaglutide GLP-1 effectively to target belly fat and achieve specific weight loss goals
Combine injections with diet, exercise, and lifestyle changes
That receptor count helps explain why these medicines are compared, but it should not be used alone to rank them
